5HT2C receptor agonists (Athersys)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Name5HT2C receptor agonists (Athersys)

Drug Alias Namenext-generation 5HT2c receptor agonists (Athersys)next-generation ATHX-105 compounds (Athersys)selective 5HT2c receptor agonists (Athersys)ATH-91385

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerotonin 2c (5-HT2c) receptor agonists

TargetsSerotonin 2c (5-HT2c) receptor

Therapy Area/IndicationsSchizophreniaObesity

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAthersys Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAthersys Inc

Active IndicationsN/A

Inactive IndicationsSchizophreniaObesity

Other Information

ATC CodeN/A